Every executable definition, side-panel definition and catalogue entry, in three groups by the licence of its
source, with its threshold in our own words and the source it is cited to. All are drafts pending review; a definition shows as reviewed only when both a clinical and a coding
approval are recorded. Default set library_default_set@1.1.
Local criteria: site choices among published definitions and named local
variants of the side-panel definitions, each with a change record, two approvals and an outcome preview.
Setting: show extended capabilities on clinician screens
Current on clinician screens: Off (default)
When on, findings from extended definitions appear on the side panel and the per-note screen under their own heading, after the core
findings. Off or on, every check runs and replays the same, and the coder view shows both groups. The guided demo's four cases are unaffected.
Thresholds are stated in our own words. Verbatim text is kept only from U.S. government works and openly licensed (CC BY)
sources, with the attribution the licence asks for; copyrighted guidelines are cited by title, body and year, with a locator.
No endorsement by the cited bodies is implied. This is not legal advice: counsel should review before commercial release.
Cancer-treatment adverse-event grading scale (NCI CTCAE): off by default
CTCAE grades describe adverse events in people receiving cancer treatment, usually in trials; they are not diagnostic criteria, and several grades depend on the laboratory reference range or on clinical descriptors that are not encoded. Using them outside that setting is a local decision for the clinical reviewer.
Current: Off (default)
When on, grading entries are shown only as "another published definition gives …" or as values needing clinical judgement; they never
raise a "not stated" item.
CDI or coding staff can change this setting. A clinician account records clinical reviews; a coding or documentation account records coding reviews: switch the demo user.
draft — pending clinical and coding review (draft)
Condition
Kidney function
Tier
measured
Licence
Kidney rule: re-sourcing pending
Source checked
not opened: re-sourcing pending
Use here
kidney check (side panel and per-note screen)
Edition
Inker et al., N Engl J Med 2021;385:1737-49 (2021 race-free eGFR equation)
Why not executable
primary equation for every eGFR on the screen
Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 2021;385:1737-49. Equation as restated by the National Kidney Foundation (CKD-EPI Creatinine Equation, 2021).
ckd_epi_2021@1.0
In our words: primary equation for every eGFR on the screen
· Inker et al., N Engl J Med 2021;385:1737-49 (2021 race-free eGFR equation) · source
cited as in the rule file; the permissive (U.S. government) sources for the same numbers are recorded in the catalogue entry kdigo_aki_ckd and arrive with the rule's next version. No endorsement by the cited bodies is implied.
Review
Reviewed only when both a clinical review and a coding review are recorded as approved.
Clinical review: none recorded yet.
Coding review: none recorded yet.
GFR and albuminuria categories, and the 3-month persistence rulekdigo_ckd_2024@1.1measuredKidney rule: re-sourcing pendingDraft · pending reviewdraft — pending clinical and coding review
Status
draft — pending clinical and coding review (draft)
Condition
Kidney function
Tier
measured
Licence
Kidney rule: re-sourcing pending
Source checked
not opened: re-sourcing pending
Use here
kidney check (side panel and per-note screen)
Edition
KDIGO 2024 CKD guideline (G/A categories, more than 3 months)
Why not executable
persistence phenotype and G/A category
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024;105(4S):S117-S314. Definition: abnormality of kidney structure or function present for more than 3 months; GFR categories G1-G5; albuminuria categories A1-A3.
kdigo_ckd_2024@1.1
In our words: persistence phenotype and G/A category
cited as in the rule file; the permissive (U.S. government) sources for the same numbers are recorded in the catalogue entry kdigo_aki_ckd and arrive with the rule's next version. No endorsement by the cited bodies is implied.
Review
Reviewed only when both a clinical review and a coding review are recorded as approved.
Clinical review: none recorded yet.
Coding review: none recorded yet.
Creatinine-change criteria and staging, with four selectable baselineskdigo_aki_2012@1.1measuredKidney rule: re-sourcing pendingDraft · pending reviewdraft — pending clinical and coding review
Status
draft — pending clinical and coding review (draft)
Condition
Kidney function
Tier
measured
Licence
Kidney rule: re-sourcing pending
Source checked
not opened: re-sourcing pending
Use here
kidney check (side panel and per-note screen)
Edition
KDIGO 2012 AKI guideline, Rec 2.1.1-2.1.2 and Table 2
Why not executable
creatinine-change criteria; baseline is a user toggle
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012;2:1-138. Recommendations 2.1.1-2.1.2 and Table 2 (staging). KDIGO does not define the baseline; the four baselines below are common choices in the literature and are shown side by side.
kdigo_aki_2012@1.1
In our words: creatinine-change criteria; baseline is a user toggle
cited as in the rule file; the permissive (U.S. government) sources for the same numbers are recorded in the catalogue entry kdigo_aki_ckd and arrive with the rule's next version. No endorsement by the cited bodies is implied.
Review
Reviewed only when both a clinical review and a coding review are recorded as approved.